Please provide your email address to receive an email when new articles are posted on . Cumming, the developer of the Crystalens (now owned by Bausch + Lomb) and founder of Cumming Ophthalmic Research ...
Please provide your email address to receive an email when new articles are posted on . While it is rare, there are some patients who will benefit from an IOL exchange. The reasons may include a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback